Search
Research
Transition to parentingPregnancy marks the transition from childlessness to parenthood, and provides an opportunity for parents-to-be to prepare, research and reflect.
Research
Transitioning From Out-of-Home Care: A Longitudinal Population-Based StudyMelissa O'Donnell BPsych (Hons), MPsych, GradDip Ed, PhD Honorary Research Associate Honorary Research Associate Areas of research expertise: Child
Research
Using ambulatory monitoring to investigate awake breathing irregularities in Rett syndrome in Australian population-based and Italian clinic samplesHelen Jenny Leonard Downs MBChB MPH BApplSci (physio) MSc PhD Principal Research Fellow Head, Child Disability +61 419 956 946 08 6319 1763
Research
Using participatory design to create impactful health promotion messages regarding alcohol use in pregnancyInvestigators: Tess Fletcher The overarching aim of this proposed research is to explore the limitations of existing alcohol and pregnancy messages
Research
UVB phototherapy for participants with an early form of multiple sclerosisMatt Prue Stephanie Cooper Hart Trend BCA Marketing, BSc Statistics and Applied Statistics, PhD BSc (Hons) MSc PhD BSc PhD Manager, Biostatistics
Research
Walkern Katatdjin (Rainbow Knowledge)Shakara Yael Bep Liddelow-Hunt Perry Uink BPhil(Hons) BPsych (Hons) MPsych (Clin) PhD BPsych(Hons.), MAppPsy(Clinical), PhD Research Assistant; PhD
Research
Young Minds MatterYoung Minds Matter is the largest survey of child and adolescent mental health and wellbeing ever conducted in Australia.
Join us for stories, imagination and connection in the Discovery Centre
A powerful screening of truth telling that captures the stories of the Western Australia Stolen Generation.
Research
The effect of azithromycin on structural lung disease in infants with cystic fibrosis (COMBAT CF): a phase 3, randomised, double-blind, placebo-controlled clinical trialStructural lung disease and neutrophil-dominated airway inflammation is present from 3 months of age in children diagnosed with cystic fibrosis after newborn screening. We hypothesised that azithromycin, given three times weekly to infants with cystic fibrosis from diagnosis until age 36 months, would reduce the extent of structural lung disease as captured on chest CT scans.